Giosan C, Cobeanu O, Wyka K, Muresan V, Mogoase C, Szentagotai A, Malta LS, Moldovan R. Cognitive evolutionary therapy versus standard cognitive therapy for depression: A single-blinded randomized clinical trial.
J Clin Psychol 2020;
76:1818-1831. [PMID:
32602592 DOI:
10.1002/jclp.22991]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2019] [Revised: 02/18/2020] [Accepted: 05/21/2020] [Indexed: 11/10/2022]
Abstract
OBJECTIVE
To compare the efficacy of cognitive evolutionary therapy (CET) with cognitive therapy (CT) for depression.
METHODS
Ninety-seven participants (78 females/19 males) were randomized to a single-blinded controlled trial (CET: n = 51 vs. CT: n = 46). Assessments were conducted at baseline, Sessions 4 and 8, posttreatment, and 3-month follow-up. Clinical diagnoses were made with Structured Clinical Interview for DSM-IV (SCID) and self-reports for depression and secondary outcomes.
RESULTS
Although both groups showed significant reductions in depressive symptomatology, the overall Time × Treatment group interaction in the intent to treat analysis was not significant (p = .770, posttreatment: d = 0.39). However, CET was superior to CT at increasing engagement in social and enjoyable activities (p = .040, posttreatment: d = 0.83, p = .040) and showed greater reductions than the CT group in behavioral inhibition/avoidance (p = .047, d = 0.62). The between-group differences generally diminished at the 3-month follow-up.
CONCLUSIONS
CET is a novel therapy for depression that may add therapeutic benefits beyond those of CT.
Collapse